Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Identification of novel in vitro antibacterial action of cloprostenol and evaluation of other non-antibiotics against multi-drug resistant A. baumannii

Abstract

A total of 24 non-antibiotic compounds were tested for their antimicrobial activity against Escherichia coli, Klebsiella pneumoniae (ATCC) and an MDR strain of Acinetobacter baumannii using an agar well diffusion assay. To study additive effects, 100 µl of each antibiotic and 50 µl of each non-antibiotic were used. Cloprostenol was the only non-antibiotic that showed antibacterial activity against all bacterial strains. Cloprostenol had an additive antimicrobial effect with the tested antibiotics against the MDR A. baumannii strain.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

References

  1. O’Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. Rev Antimicrob Resist. 2014;20:1–16.

    Google Scholar 

  2. Organization WHO. WHO publishes list of bacteria for which new antibiotics are urgently needed. Geneva: WHO; 2017. http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/.

  3. Kim T, et al. Natural prognosis of carbapenem resistant Acinetobacter baumannii bacteremia in patients who did not receive appropriate antibiotic treatment: a retrospective multicenter study in Korea. Medicine. 2018;97:e12984.

    Article  Google Scholar 

  4. Li L, et al. Antimicrobial resistance and pathogen distribution in hospitalized burn patients: a multicenter study in Southeast China. Medicine. 2018;97:e11977.

    Article  Google Scholar 

  5. Tekin R, et al. Risk factors for nosocomial burn wound infection caused by multidrug resistant Acinetobacter baumannii. J Burn Care Res. 2014;35:e73–e80.

    Article  Google Scholar 

  6. Begum S, Hasan F, Hussain S, Shah AA. Prevalence of multi drug resistant Acinetobacter baumannii in the clinical samples from tertiary care hospital in Islamabad, Pakistan. Pak J Med Sci. 2013;29:1253–8.

    PubMed  PubMed Central  Google Scholar 

  7. Jamal S, Al Atrouni, Rafei R, et al. Molecular mechanisms of antibiotic resistance in Acinetobacter baumannii with a special focus on its epidemiology in Lebanon. J Glob Antimicrob Resist. 2018;15:154–63.

    Article  Google Scholar 

  8. Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45:568–85.

    Article  CAS  Google Scholar 

  9. Qureshi ZA, et al. Colistin-resistant Acinetobacter baumannii: beyond carbapenem resistance. Clin Infect Dis. 2015;60:1295–303.

    Article  Google Scholar 

  10. Bonnin RA, Nordmann P, Poirel L. Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art. Expert Rev Anti Infect Ther. 2013;11:571–83.

    Article  CAS  Google Scholar 

  11. Roca I, Espinal P, Vila-Farrés X, Vila J. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drug-resistant menace. Front Microbiol. 2012;3:148.

    Article  Google Scholar 

  12. Hujer KM, et al. Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother. 2005;49:2941–8.

    Article  CAS  Google Scholar 

  13. Bou G, Oliver A, Martinez-Beltran J. OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother. 2000;44:1556–61.

    Article  CAS  Google Scholar 

  14. Fournier PE, Vallenet D, Barbe V, Audic S, Ogata H, Poirel L, et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2006;2:e7.

    Article  Google Scholar 

  15. Adams MD, et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother. 2009;53:3628–34.

    Article  CAS  Google Scholar 

  16. Beceiro A, et al. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system. Antimicrob Agents Chemother. 2011;55:3370–9.

    Article  CAS  Google Scholar 

  17. Magnet S, Courvalin P, Lambert T. Resistance–nodulation–cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob Agents Chemother. 2001;45:3375–80.

    Article  CAS  Google Scholar 

  18. Lin MF, Lin YY, Lan CY. Contribution of EmrAB efflux pumps to colistin resistance in Acinetobacter baumannii. J Microbiol. 2017;55:130–6.

    Article  CAS  Google Scholar 

  19. Chiu CH, et al. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan. Int J Antimicrob Agents. 2010;35:382–6.

    Article  CAS  Google Scholar 

  20. D’Arezzo S, et al. Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy). Clin Microbiol Infect. 2009;15:347–57.

    Article  Google Scholar 

  21. Kumar S, Marwaha N, Singh D, Kumar V. Evaluating the antibacterial activity of plant extracts against bacterial pathogens. J Drug Deliv Ther. 2012;2:182–5.

    Google Scholar 

  22. Hassan KU, et al. Influence of Moringaoleifera decorticated seed meal on broiler performance and immunity. Pak Vet J. 2017;37:47–50.

    Google Scholar 

  23. Shahzad S, Ashraf MA, Sajid M, Shahzad A, Rafique A, Mahmood MS. Evaluation of synergistic antimicrobial effect of vitamins (A, B1, B2, B6, B12, C, D, E and K) with antibiotics against resistant bacterial strains. J Glob Antimicrob Resist. 2018;13:231–6.

    Article  Google Scholar 

  24. Yotis W, Waner J. Antimicrobial properties of testosterone and its intermediates. Antonie Van Leeuwenhoek. 1968;34:275–86.

    Article  CAS  Google Scholar 

  25. Min C, et al. The antimicrobial activity of the appetite peptide hormone ghrelin. Peptides. 2012;36:151–6.

    Article  CAS  Google Scholar 

  26. Modric T, Momcilovic D, Gwin WE, Peter AT. Hormonal and antimicrobial therapy in theriogenology practice: currently approved drugs in the USA and possible future directions. Theriogenology. 2011;76:393–408.

    Article  CAS  Google Scholar 

  27. Kaufmann TB, Westermann S, Drillich M, Plöntzke J, Heuwieser W. Systemic antibiotic treatment of clinical endometritis in dairy cows with ceftiofur or two doses of cloprostenol in a 14-d interval. Anim Reprod Sci. 2010;121:55–62.

    Article  CAS  Google Scholar 

  28. Lewis GS. Steroidal regulation of uterine immune defences. Anim Reprod Sci. 2004;82:281–94.

    Article  Google Scholar 

  29. Valgas C, Souza SMD, Smânia EF, Smânia A Jr. Screening methods to determine antibacterial activity of natural products. Braz J Microbiol 2007;38:369–80.

    Article  Google Scholar 

  30. Khalil AT, Khan I, Ahmad K, Khan YA, Khan M, Khan M. Synergistic antibacterial effect of honey and Herba Ocimi Basilici against some bacterial pathogens. J Tradit Chin Med 2013;33:810–4.

    Article  Google Scholar 

  31. Bonev B, Hooper J, Parisot J. Principles of assessing bacterial susceptibility to antibiotics using the agar diffusion method. J Antimicrob Chemother. 2008;61:1295–301.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

SS involved in the basic concept and design of study and flow up with experiments; also involved in the evaluation of results and data analysis; involved in drafting of article from initial stage. MW involved in the final data assessment in figures; involved in critical revision; also involved in the final approval of the manuscript. AS involved in the study design materials and methods; involved in the critical revision of the manuscript.

Corresponding author

Correspondence to Shakeel Shahzad.

Ethics declarations

Conflict of interest

The authors declared that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shahzad, S., Willcox, M. & Shahzad, A. Identification of novel in vitro antibacterial action of cloprostenol and evaluation of other non-antibiotics against multi-drug resistant A. baumannii. J Antibiot 73, 72–75 (2020). https://doi.org/10.1038/s41429-019-0244-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41429-019-0244-2

This article is cited by

Search

Quick links